Clinical Applications for MMDx®: Gene Expression Profiling in Transplant Biopsies
ESOT 2021 Symposium
Moderator: Dr. Christopher Lawrence, Director, Medical Affairs | Thermo Fisher Scientific
Guest Speaker: Georg Böhmig, MD | Medical University of Vienna • Vienna, Austria
With a future effective LCD announced for molecular testing for solid organ allograft rejection, clinicians may now consider applying molecular gene expression profiling in a variety of clinical cases. In this presentation, Dr. Böhmig explores the use of MMDx-Kidney and MMDx-Heart for the management of post-transplant kidney and heart patients. A variety of case studies are presented where molecular assessment was applied to diagnose allograft dysfunction and to determine if rejection was due to antibody-mediated rejection (ABMR), T-cell-mediated rejection (TCMR), or a combination of both.
Share This Page
